High-grade serous tubo-ovarian carcinoma presenting as paraneoplastic cerebellar degeneration

被引：0
|
作者：
Butt, E. [1 ]
Chadda, K. R. [1 ,2 ]
Tadross, J. A. [3 ]
Latimer, J. [4 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England
[2] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England
[3] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Metab Dis Unit,Metab Res Labs,Wellcome Trust, Cambridge, England
[4] Addenbrookes Hosp, Div Gynaecol Oncol, Dept Gynaecol, Cambridge, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1362
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [21] Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)
    Ditzel, Helena M.
    Strickland, Kyle C.
    Meserve, Emily E.
    Stover, Elizabeth
    Konstantinopoulos, Panagiotis A.
    Matulonis, Ursula A.
    Muto, Michael G.
    Liu, Joyce F.
    Feltmate, Colleen
    Horowitz, Neil
    Berkowitz, Ross S.
    Gupta, Mamta
    Hecht, Jonathan L.
    Lin, Douglas I.
    Jochumsen, Kirsten M.
    Welch, William R.
    Hirsch, Michelle S.
    Quade, Bradley J.
    Lee, Kenneth R.
    Crum, Christopher P.
    Mutter, George L.
    Nucci, Marisa R.
    Howitt, Brooke E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (03) : 230 - 240
  • [22] Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
    Zwimpfer, T. A.
    Pandey, A.
    Fereday, S.
    Coelho, R. J. B-N.
    Twomey, L.
    Ariyaratne, D.
    Traficante, N.
    Jacob, F.
    Eller, R.
    Heinzelmann-Schwarz, V.
    Christie, E. L.
    Kennedy, C.
    Au-Yeung, G.
    Ramus, S.
    Koebel, M.
    Nelson, B.
    Goode, E. L.
    DeFazio, A.
    Bowtell, D. D. L.
    Garsed, D. W.
    ANNALS OF ONCOLOGY, 2024, 35 : S571 - S571
  • [23] Quantifying intratumoral biomarker heterogeneity in tubo-ovarian high-grade serous carcinoma to optimize clinical translation
    Talhouk, Aline
    Chiu, Derek S.
    Meunier, Liliane
    Rahimi, Kurosh
    Le Page, Cecile
    Bernard, Monique
    Provencher, Diane
    Huntsman, David G.
    Masson, Anne Marie Mes
    Kobel, Martin
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [24] The prognostic value of the chemotherapy response score in tubo-ovarian or primary peritoneal high-grade serous carcinoma
    Weirich, Larissa
    Bodinaku, Ina
    Bradford, Leslie
    Craig, Wendy
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S231 - S232
  • [25] Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer-The Possibility or the Necessity?
    Wilczynski, Jacek
    Paradowska, Edyta
    Wilczynski, Milosz
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (01):
  • [26] A Proteogenomic Analysis of Transitional Cell Carcinoma, the TCC-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn
    Karnezis, Anthony
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Soslow, Robert
    Morin, Gregg
    Hughes, Christopher
    Piskorz, Anna
    Cheng, Angela
    Greening, Kendall
    Prader, Sonja
    Pfisterer, Jacobus
    Gilks, C. Blake
    Kommoss, Stefan
    Brenton, James
    Huntsman, David
    Kommoss, Friedrich
    LABORATORY INVESTIGATION, 2019, 99
  • [27] Tubo-ovarian high-grade serous carcinomas commonly express CA19.9
    Rajendran, Simon
    McCluggage, W. Glenn
    HISTOPATHOLOGY, 2022, 80 (02) : 449 - 450
  • [28] A Proteogenomic Analysis of Transitional Cell Carcinoma, the TCC-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma
    Tessier-Cloutier, Basile
    Cochrane, Dawn
    Karnezis, Anthony
    Colborne, Shane
    Magrill, Jamie
    Talhouk, Aline
    Zhang, Jonathan
    Soslow, Robert
    Morin, Gregg
    Hughes, Christopher
    Piskorz, Anna
    Cheng, Angela
    Greening, Kendall
    Prader, Sonja
    Pfisterer, Jacobus
    Gilks, C. Blake
    Kommoss, Stefan
    Brenton, James
    Huntsman, David
    Kommoss, Friedrich
    MODERN PATHOLOGY, 2019, 32
  • [29] HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma
    Koskela, Heidi
    Li, Yilin
    Joutsiniemi, Titta
    Muranen, Taru
    Isoviita, Veli-Matti
    Huhtinen, Kaisa
    Micoli, Giulia
    Lavikka, Kari
    Marchi, Giovanni
    Hietanen, Sakari
    Virtanen, Anni
    Hautaniemi, Sampsa
    Oikkonen, Jaana
    Hynninen, Johanna
    GYNECOLOGIC ONCOLOGY, 2024, 180 : 91 - 98
  • [30] Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide
    Singh, Naveena
    Gilks, C. Blake
    Hirschowitz, Lynn
    Kehoe, Sean
    McNeish, Iain A.
    Miller, Dianne
    Naik, Raj
    Wilkinson, Nafisa
    McCluggage, W. Glenn
    GYNECOLOGIC ONCOLOGY, 2016, 141 (02) : 195 - 198
12345